S. Basci Et Al. , "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1676-1682, 2020
Basci, S. Et Al. 2020. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7 , 1676-1682.
Basci, S., Ata, N., Altuntas, F., Yigenoglu, T. N., Dal, M. S., Korkmaz, S., ... Namdaroglu, S.(2020). Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, 1676-1682.
Basci, Semih Et Al. "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, 1676-1682, 2020
Basci, Semih Et Al. "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1676-1682, 2020
Basci, S. Et Al. (2020) . "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1676-1682.
@article{article, author={Semih Basci Et Al. }, title={Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2020, pages={1676-1682} }